Laura Wake

Also affiliated with U-M Rogel Cancer Center

MedicineImmunology and MicrobiologyComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naïve chronic lymphocytic leukemia: a phase 2 study”.

Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naïve chronic lymphocytic leukemia: a phase 2 study

Leukemia & lymphoma/Leukemia and lymphoma(2021)10.1080/10428194.2021.1888379

N/A

0.286DataRank · unranked

4 citations

Clifton C. Mo, Erika M. Gaglione, Constance M. Yuan, Maryalice Stetler‐Stevenson, Xin Tian +20 more

Flow cytometric analysis of fine needle aspirates is affected by tumor subtype, but not by anatomic location nor technique

Diagnostic Cytopathology(2020)10.1002/dc.24417

N/A

0DataRank · unranked

1 citations

Christopher J. VandenBussche, Syed Z. Ali, Nina D. Wagner‐Johnston, Kathleen H. Burns, Christopher D. Gocke +4 more